Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Hatleberg, C I; Ryom, L; d'Arminio Monforte, A; Fontas, E; Reiss, P; Kirk, O; El-Sadr, W; Phillips, A; de Wit, S; Dabis, F; Weber, R; Law, M; Lundgren, J D; Sabin, C (2018). Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. HIV Medicine, 19(9):605-618.

Achhra, A C; Mocroft, A; Reiss, P; Sabin, C; Ryom, L; de Wit, S; Smith, C J; d'Arminio Monforte, A; Phillips, A; Weber, R; Lundgren, J; Law, M G (2016). Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Medicine, 17(4):255-268.

Mocroft, A; Furrer, H J; Miro, J M; Reiss, P; Mussini, C; Kirk, O; Abgrall, S; Ayayi, S; Bartmeyer, B; Braun, D; Castagna, A; d'Arminio Monforte, A; Gazzard, B; Gutierrez, F; Hurtado, I; Jansen, K; Meyer, L; Muñoz, P; Obel, N; Soler-Palacin, P; Papadopoulos, A; Raffi, F; Ramos, J T; Rockstroh, J K; Salmon, D; Torti, C; Warszawski, J; de Wit, S; Zangerle, R; Fabre-Colin, C; Kjaer, J; Chene, G; Grarup, J; Lundgren, J D (2013). The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clinical Infectious Diseases, 57(7):1038-1047.

Petoumenos, K; Worm, S; Reiss, P; de Wit, S; D'Arminio Monforte, A; Sabin, C; Friis-Møller, N; Weber, R; Mercie, P; Pradier, C; El-Sadr, W; Kirk, O; Lundgren, J; Law, M (2011). Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study. HIV Medicine, 12(7):412-421.

This list was generated on Wed Oct 17 13:27:04 2018 CEST.